News

Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th

ASHBURN, Va., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its second quarter 2022 financial results will be reported on Thursday, August 18, 2022 before the open of the financial markets. Management will also host a webcast and conference call on August 18, 2022 at 8:30 a.m. ET to discuss the results and provide a corporate update.

08/11/2022

Why Is Quoin Pharmaceuticals (QNRX) Stock Up 93% Today?

QNRX stock is nearly doubling after the company sought permission to cancel an announcement of share sales. The post Why Is Quoin Pharmaceuticals (QNRX) Stock Up 93% Today?

07/01/2022

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Quoin Pharmaceuticals, Ltd. (QNRX) a buy, sell, or hold?

Quoin Pharmaceuticals, Ltd. (QNRX) can sell. Click on Rating Page for detail.

What is Quoin Pharmaceuticals, Ltd.'s stock price?

The price of Quoin Pharmaceuticals, Ltd. (QNRX) is 5.4 and it was updated on 2022-08-17 07:00:45.

Is Quoin Pharmaceuticals, Ltd. (QNRX) overvalued or undervalued?

Currently Quoin Pharmaceuticals, Ltd. (QNRX) is in undervalued.

News

From:

To:

News
Best Penny Stocks To Buy Right Now? 4 To Watch Under $1 Penny stocks under $1 to watch. The post Best Penny Stocks To Buy Right Now? Fri, Jul. 01, 2022
Penny Stocks To Buy Now? 4 To Watch With Big News Penny stocks to watch The post Penny Stocks To Buy Now? 4 To Watch With Big News appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. Mon, Jun. 06, 2022
Why Quoin Pharmaceuticals Stock Is Trading Higher Quoin Pharmaceuticals (NASDAQ: QNRX) shares are trading higher Monday after the company announced it received U.S. Food and Drug Administration clearance to initiate clinical testing for its Investigational New Drug application for QRX003. QRX003 is Quoin's investigational product for. Mon, Apr. 25, 2022
Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today What are the best penny stocks to buy today? The post Best Reddit Penny Stocks To Buy Now? Fri, Jan. 07, 2022
Best Penny Stocks to Buy as 2021 Ends? 3 to Watch Right Now Making a penny stocks watchlist today? Check these three out The post Best Penny Stocks to Buy as 2021 Ends? Tue, Dec. 21, 2021

SEC Filings

SEC Filings
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 08/12/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - POS EX SEC Filings 08/11/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/11/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 08/11/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 08/08/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B4 SEC Filings 08/08/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1MEF SEC Filings 08/05/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1/A SEC Filings 08/04/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1 SEC Filings 08/02/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 07/15/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 07/15/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - RW SEC Filings 06/30/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/16/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 06/16/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-3 SEC Filings 06/14/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/13/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 06/13/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/06/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 06/06/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 05/23/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 05/23/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/28/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 04/28/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 424B3 SEC Filings 04/26/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 04/25/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 04/22/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 04/21/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - F-1 SEC Filings 04/14/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/13/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F SEC Filings 04/13/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/28/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 03/10/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/08/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 02/14/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 02/10/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 02/07/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/31/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 01/11/2022
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 12/17/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/23/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 11/12/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/29/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/15/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/27/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/20/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/17/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/10/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/02/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/24/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 08/13/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - EFFECT SEC Filings 08/12/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - F-4/A SEC Filings 08/10/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 08/10/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - F-4/A SEC Filings 08/06/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 08/05/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 25-NSE SEC Filings 08/03/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 07/30/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - F-4/A SEC Filings 07/16/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - CORRESP SEC Filings 07/16/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - UPLOAD SEC Filings 06/30/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/17/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - F-4 SEC Filings 06/16/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 06/03/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 04/19/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/29/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 20-F SEC Filings 03/29/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 03/24/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G/A SEC Filings 02/16/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K/A - Current report SEC Filings 02/11/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - SC 13G SEC Filings 01/13/2021
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/20/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/09/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 11/02/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/29/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/22/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/20/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 10/13/2020
Quoin Pharmaceuticals, Ltd. (QNRX) - 6-K - Current report SEC Filings 09/25/2020

Press Releases

StockPrice Release
Quoin pharmaceuticals announces pricing of $16.8 million upsized public offering 08/05/2022
Quoin pharmaceuticals and endo ventures limited enter into exclusive distribution and supply agreements 07/15/2022
Endo announces agreement for paladin labs to develop, commercialize and supply quoin pharmaceuticals' qrx003 in canada 07/15/2022
Quoin pharmaceuticals announces opening of first clinical site for netherton syndrome clinical study 07/06/2022
Quoin pharmaceuticals receives nasdaq deficiency notice regarding minimum bid price requirement 06/15/2022
Quoin pharmaceuticals announces licensing and distribution agreement with leading rare disease company for greater china 06/15/2022
Quoin pharmaceuticals: strategically building for future success 06/14/2022
Quoin pharmaceuticals announces fda clearance of ind for its lead asset, qrx003, for netherton syndrome 04/25/2022
Quoin pharmaceuticals targeting regulatory approvals for lead candidate for netherton syndrome in 2024 03/24/2022
Quoin pharmaceuticals announces submission of ind for its lead asset, qrx003, for netherton syndrome 03/15/2022
Quoin pharmaceuticals submits scientific advice briefing document to ema for its lead asset, qrx003, for netherton syndrome 03/10/2022
Quoin pharmaceuticals extends exclusive distribution agreement with er-kim for its lead asset, qrx003, for netherton syndrome 03/01/2022
Quoin pharmaceuticals signs exclusive distribution agreement with neopharm for its lead asset, qrx003, for netherton syndrome 02/17/2022
Changing lives, delivering value: quoin pharmaceuticals is making the balancing act look easy 02/08/2022
The r&d sweet spot: quoin pharmaceuticals delivering value-based drug development through rare and orphan disease therapeutics 12/14/2021
Quoin pharmaceuticals poised for rapid commercialization of promising pipeline 11/16/2021
Quoin pharmaceuticals and genpharm services sign exclusive license and distribution agreement for quoin's lead asset, qrx003 11/11/2021
Quoin pharmaceuticals signs exclusive licensing and distribution agreement with aft pharmaceuticals for its lead asset, qrx003 11/08/2021
Quoin pharmaceuticals appoints gordon dunn as chief financial officer 11/04/2021

Unlock

QNRX Ratings Summary

QNRX Quant Ranking

Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th

Why Is Quoin Pharmaceuticals (QNRX) Stock Up 93% Today?

Is Quoin Pharmaceuticals, Ltd. (QNRX) a buy, sell, or hold?

What is Quoin Pharmaceuticals, Ltd.'s stock price?

Is Quoin Pharmaceuticals, Ltd. (QNRX) overvalued or undervalued?

Best Penny Stocks To Buy Right Now? 4 To Watch Under $1

Penny Stocks To Buy Now? 4 To Watch With Big News

Why Quoin Pharmaceuticals Stock Is Trading Higher

Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today

Best Penny Stocks to Buy as 2021 Ends? 3 to Watch Right Now

Company Details

Ratings

Quant Factor Grades

Trading

Dividend Grades

Dividend

Earnings

Valuation

Growth

Performance

Momentum

Profitability

Risk

Ownership

Debt